GR3035170T3 - ANALOGUES OF hGH-RH (1-29)NH 2? HAVING ANTAGONISTIC ACTIVITY - Google Patents

ANALOGUES OF hGH-RH (1-29)NH 2? HAVING ANTAGONISTIC ACTIVITY

Info

Publication number
GR3035170T3
GR3035170T3 GR20000402857T GR20000402857T GR3035170T3 GR 3035170 T3 GR3035170 T3 GR 3035170T3 GR 20000402857 T GR20000402857 T GR 20000402857T GR 20000402857 T GR20000402857 T GR 20000402857T GR 3035170 T3 GR3035170 T3 GR 3035170T3
Authority
GR
Greece
Prior art keywords
hgh
analogues
antagonistic activity
antagonistic
activity
Prior art date
Application number
GR20000402857T
Other languages
English (en)
Inventor
Andrew V Schally
Marta Zarandi
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of GR3035170T3 publication Critical patent/GR3035170T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR20000402857T 1993-12-17 2000-12-29 ANALOGUES OF hGH-RH (1-29)NH 2? HAVING ANTAGONISTIC ACTIVITY GR3035170T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/168,810 US5550212A (en) 1993-12-17 1993-12-17 Analogues of hGH-RH(1-29)NH2 having antagonistic activity
PCT/US1994/013714 WO1995016707A1 (en) 1993-12-17 1994-11-28 ANALOGUES OF hGH-RH (1-29)NH2 HAVING ANTAGONISTIC ACTIVITY

Publications (1)

Publication Number Publication Date
GR3035170T3 true GR3035170T3 (en) 2001-04-30

Family

ID=22613022

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000402857T GR3035170T3 (en) 1993-12-17 2000-12-29 ANALOGUES OF hGH-RH (1-29)NH 2? HAVING ANTAGONISTIC ACTIVITY

Country Status (13)

Country Link
US (1) US5550212A (el)
EP (1) EP0734396B1 (el)
JP (1) JPH09506616A (el)
AU (1) AU695315B2 (el)
CA (1) CA2178218A1 (el)
DE (1) DE69426270T2 (el)
DK (1) DK0734396T3 (el)
ES (1) ES2152380T3 (el)
GR (1) GR3035170T3 (el)
NZ (1) NZ277926A (el)
PT (1) PT734396E (el)
WO (1) WO1995016707A1 (el)
ZA (1) ZA949641B (el)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792747A (en) * 1995-01-24 1998-08-11 The Administrators Of The Tulane Educational Fund Highly potent agonists of growth hormone releasing hormone
US5942489A (en) * 1996-05-03 1999-08-24 The Administrators Of The Tulane Educational Fund HGH-RH(1-29)NH2 analogues having antagonistic activity
AU768516B2 (en) * 1998-06-03 2003-12-18 Ardana Bioscience Limited Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
US6124263A (en) * 1998-11-16 2000-09-26 Asta Medica Ag Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
US6057422A (en) * 1998-11-25 2000-05-02 The Administrators Of The Tulane Educational Fund Antagonistic analogs of GH-RH inhibiting IGF-I and -II
FR2821359B1 (fr) 2001-02-27 2003-05-09 Sod Conseils Rech Applic L'heterocarpine, une proteine fixant le ghrh humain
FR2843697B1 (fr) * 2002-08-26 2005-12-09 Sod Conseils Rech Applic L'heterocarpine, une proteine d'origine vegetale aux proprietes anticancereuses
US7494969B2 (en) 2002-02-26 2009-02-24 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Heterocarpine, a plant-derived protein with anti-cancer properties
US8691942B2 (en) 2008-03-28 2014-04-08 University Of Miami N- and C- terminal substituted antagonistic analogs of GH-RH
CN107446053A (zh) 2008-06-12 2017-12-08 益普生生物创新有限公司 癌症的抑制
KR101642363B1 (ko) 2008-06-12 2016-07-25 입센 바이오이노베이션 리미티드 신경내분비계 질환의 억제
GB0820970D0 (en) 2008-11-17 2008-12-24 Syntaxin Ltd Suppression of cancer
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
CA2965696A1 (en) 2014-11-12 2016-05-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Treatment of hormonal disorders of growth
WO2017075535A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions
AU2020218272A1 (en) 2019-02-08 2021-09-02 United States Government As Represented By The Department Of Veterans Affairs Growth hormone-releasing hormone antagonists and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518586A (en) * 1983-01-13 1985-05-21 The Salk Institute For Biological Studies GRF Analogs III
US4628043A (en) * 1983-04-26 1986-12-09 The Salk Institute For Biological Studies Hypothalamic GRF agonists
US4626523A (en) * 1983-09-13 1986-12-02 The Salk Institute For Biological Studies GRF analogs II
US4528190A (en) * 1983-10-25 1985-07-09 The Salk Institute For Biological Studies GRF Analogs IV
US4659693A (en) * 1984-04-30 1987-04-21 Syntex (U.S.A.) Inc. N,N'-dialkyl substituted guanidino amino acyl residue substituted GRF-analog peptides
FR2567524B1 (fr) * 1984-07-10 1987-11-27 Sanofi Sa Procede de synthese de la somatocrinine en phase liquide et peptides intermediaires
US4649131A (en) * 1984-09-24 1987-03-10 Hoffmann-La Roche Inc. Growth hormone releasing factor analogs
US4622312A (en) * 1984-09-24 1986-11-11 Hoffmann-La Roche Inc. Growth hormone releasing factor analogs
CA1271600A (en) * 1985-01-07 1990-07-10 David Howard Coy Growth hormone-releasing peptides and method of treating mammals therewith
US4689318A (en) * 1985-08-29 1987-08-25 The Salk Institute For Biological Studies GRF analogs
US4880778A (en) * 1986-05-12 1989-11-14 Eastman Kodak Company Combinations having synergistic growth hormone releasing activity and methods for use thereof
US4784987A (en) * 1987-01-13 1988-11-15 The Salk Institute For Biological Studies GRF analogs VI
US4914189A (en) * 1987-02-05 1990-04-03 The Adminstrators Of The Tulane Educational Fund Synthetic GHRH analogs
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
US5084555A (en) * 1989-08-21 1992-01-28 The Administrators Of The Tulane Educational Fund An octapeptide bombesin analog
EP0413839A1 (en) * 1989-08-22 1991-02-27 The Administrators of The Tulane Educational Fund GHRH analogs
EP0527914A4 (en) * 1990-05-04 1993-08-11 The Administrators Of The Tulane University Educational Fund Novel synthetic grf analogs
JP3051145B2 (ja) * 1990-08-28 2000-06-12 住友製薬株式会社 新規なポリエチレングリコール誘導体修飾ペプチド
JP2707938B2 (ja) * 1993-01-06 1998-02-04 株式会社ニコン 発光素子を有するカメラおよび電子閃光装置

Also Published As

Publication number Publication date
NZ277926A (en) 1997-12-19
PT734396E (pt) 2001-04-30
WO1995016707A1 (en) 1995-06-22
DE69426270D1 (de) 2000-12-14
AU1332295A (en) 1995-07-03
DK0734396T3 (da) 2001-02-12
ZA949641B (en) 1995-08-25
US5550212A (en) 1996-08-27
CA2178218A1 (en) 1995-06-22
JPH09506616A (ja) 1997-06-30
AU695315B2 (en) 1998-08-13
DE69426270T2 (de) 2001-07-05
ES2152380T3 (es) 2001-02-01
EP0734396A1 (en) 1996-10-02
EP0734396B1 (en) 2000-11-08

Similar Documents

Publication Publication Date Title
EG20582A (en) Antiparasitic agents
PL304822A1 (en) Novel sulfonamides and pharmaceutic agent
GR3035170T3 (en) ANALOGUES OF hGH-RH (1-29)NH 2? HAVING ANTAGONISTIC ACTIVITY
HU9200302D0 (en) 1,3-oxatiolane-nucleotide analogues
EP0332326A3 (en) Polyurethane coating compositions
IL110018A0 (en) Biologically active vasopressin analogues
GB9312154D0 (en) Antiparasitic agents
ZA891079B (en) (5(6)(1h-azole-1-ylmethyl)benzimidazole)carbamates
PL305981A1 (en) Biologically active ureido derivatives useful as ananti-metastatic agents
GB8910229D0 (en) Fastening gun
PL299869A1 (en) Pyridyl-sulfonyl ureas
CS316085A2 (en) Zpusob pripravy adicni soli s kyselinou, odvozene od 2( 2 amino ethyl thiomethyl) 5 dimethylaminomethylfuranu
CS351287A1 (en) Kmen mikroorganizmu bacillus cereus ccm 3993
HU210812A9 (en) N-alkyl-2-substituted atp analogues
GB8816123D0 (en) Immunosuppressive agents
GB9306373D0 (en) Sulphonated aryl ureas
CS522186A1 (en) Sposob pripravy dimetylaminovej soli 2 metyl 4 chlorfenoxyoctovej kyseliny
CS522486A1 (en) Sposob vyroby dimetylaminovej soli 2 metyl 4 chlorfenoxyoctovej kyseliny
GB9222203D0 (en) Nucleoside analogues
CS756386A1 (en) Substituovane 5 amino 6 (4 pentyloxyfenyl) 3(2h) pyridazinony
CS756586A1 (en) Zpusob pripravy 5 amino 6 (4 pentyloxyfenyl) 3(2h) pyridazinonu
CS379886A1 (en) Sposo vyroby soli s alkalickym kovom alebo alkalickych zemin 2 metyl 4 chlorfenoxyoctovej kyseliny
CS821385A1 (en) Sposob cistenia 2 amino n (1 metyletyl)benzamidu
CS731886A1 (en) Zpusob pripravy 2 amino 5 nitrothiobenzamidu
CS504186A1 (en) Zpusob pripravy 5 amino 2 acylaminofenolu

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees